Focus on Molecules: Myocilin/TIGR.
Focus on Molecules: Myocilin/TIGR.
复制标题
关注分子:Myocilin/TIGR。
DOI:
10.1016/j.exer.2005.06.014
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Tamm,ErnstR
中科院分区:
文献类型:
--
作者:
Ricard,CynthiaS;Tamm,ErnstR
Myocilin/TIGR(accession numbers: Nucleotide AH006047, Protein NP_000252) was the first molecule discovered to be causative for some forms of primary open angle glaucoma (POAG)(for a more detailed review see Tamm, 2002). POAG is a neurodegenerative disease characterized by progressive cupping of the optic disk, remodeling of the optic nerve head tissue, optic nerve degeneration, and, if uncontrolled, blindness. Elevated intraocular pressure (IOP) is the major risk factor for glaucoma. IOP is increased in patients with POAG because of an abnormally high outflow resistance for aqueous humor in the trabecular meshwork (TM). As treatment of patients with glucocorticoids was known to increase IOP and to cause steroid induced glaucoma, Jon Polansky and coworkers studied dexamethasone-induced proteins in cultured TM cells. In the course of these studies, a 55–57kDa secreted glycoprotein was discovered and named trabecular meshwork-induced glucocorticoid response protein (TIGR). In independent studies by Kubota and coworkers, the same protein was discovered in the retina and named myocilin. Subsequently, Stone and coworkers discovered that mutations in myocilin/TIGR were causative for GLC1A-linked open angle glaucoma mapped to chromosome 1q24. 3–q25. 2.(OMIM 601652)